Recovery act - sequencing for the cancer genome atlas (tcga) program

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000055C
Awardee
Awarding agency
Obligated
$30,964,126

Award facts

Opportunity
Contract value 19% obligated
  • $30,964,126.48 Current, with exercised options
  • $166,819,979.48 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Cambridge, MA 02142, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 11 -$941
Other Administrative Action 10 $0
Other Administrative Action 9 $0
Other Administrative Action 8 $0
Other Administrative Action 7 $0
Other Administrative Action 6 · Other functions recovery act - sequencing for the cancer genome atlas (tcga) program $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 · Arra::yes::arra recovery act - sequencing for the cancer genome atlas (tcga) program -$34,933
Exercise an Option 1 $4,000,000
Original award $27,000,000
Show all 12

About this award

This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic sequencing, data analysis, genome engineering, and translational research. This contract is not set-aside. The Broad Institute frequently partners with academic medical centers and receives substantial grant funding from the National Institutes of Health (NIH) to support research in areas like cancer, neuroscience, and infectious disease. The Broad Institute also holds two indefinite delivery contracts with the NIH to provide genomics data generation, analysis, and management services for major research initiatives.

Quick answers

Who was awarded contract HHSN261201000055C?

HHSN261201000055C was awarded to The Broad Institute, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2010.

How much is contract HHSN261201000055C worth?

The government has obligated $30,964,126 on HHSN261201000055C. Its potential value, with all options, is $166,819,979.

Was contract HHSN261201000055C competed?

The extent of competition for HHSN261201000055C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award